Literature DB >> 15717326

Proteomics analysis of growth hormone isoforms in the human pituitary.

Xianquan Zhan1, Francesco Giorgianni, Dominic M Desiderio.   

Abstract

In order to elucidate the roles of human growth hormone (hGH) in the normal (control) pituitary and in adenomas, the hGH isoforms in the human pituitary were analyzed with two-dimensional gel electrophoresis, immobilized metal affinity column (Ga(+3)) chromatography, mass spectrometry (MS), and bioinformatics. Twenty-four hGH-containing proteins, with significantly different expression proportions of their isoforms were found. The proportions of isoforms were as follows: isoform 1 (87.5%) > isoform 2 (8.1%) > isoform 3 (3.3%) > isoform 4 (1.1%). Deamidation of asparagine to aspartate was identified with matrix-assisted laser desorption/ionization-time of flight MS. Tandem mass spectrometry data demonstrated that hGH is a phosphoprotein (spot 6); phosphorylation was found at Ser-77 in the tryptic peptide (68)YSFLQNPQTSLCFSESIPTPSNR(90), at Ser-176 in the tryptic peptide (172)FDTNSHNDDALLK(184), and at Ser-132 in the peptide (126)SLVYGASDSNVYDLLK(141). The phosphorylation sites at Ser-77 and Ser-176 were consistent with computer-program predictions (NetPhos). These results provide novel clues for further studies of the functions, and mechanisms of action, of hGH in the human pituitary and in growth hormone-related diseases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15717326     DOI: 10.1002/pmic.200400987

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  23 in total

1.  Human growth hormone: 45-kDa isoform with extraordinarily stable interchain disulfide links has attenuated receptor-binding and cell-proliferative activities.

Authors:  Juan J Bustamante; Alexei L Grigorian; Jesus Muñoz; Roberto M Aguilar; Lisa R Treviño; Andrew O Martinez; Luis S Haro
Journal:  Growth Horm IGF Res       Date:  2010-05-15       Impact factor: 2.372

2.  Two-dimensional Gel Electrophoresis Coupled with Mass Spectrometry Methods for an Analysis of Human Pituitary Adenoma Tissue Proteome.

Authors:  Xianquan Zhan; Yuda Huang; Ying Long
Journal:  J Vis Exp       Date:  2018-04-02       Impact factor: 1.355

Review 3.  Stability of protein pharmaceuticals: an update.

Authors:  Mark Cornell Manning; Danny K Chou; Brian M Murphy; Robert W Payne; Derrick S Katayama
Journal:  Pharm Res       Date:  2010-02-09       Impact factor: 4.200

Review 4.  Pattern recognition for predictive, preventive, and personalized medicine in cancer.

Authors:  Tingting Cheng; Xianquan Zhan
Journal:  EPMA J       Date:  2017-03-09       Impact factor: 6.543

5.  Quantitative proteomics revealed energy metabolism pathway alterations in human epithelial ovarian carcinoma and their regulation by the antiparasite drug ivermectin: data interpretation in the context of 3P medicine.

Authors:  Na Li; Huanni Li; Ya Wang; Lanqin Cao; Xianquan Zhan
Journal:  EPMA J       Date:  2020-10-10       Impact factor: 6.543

6.  Activation of the GH/IGF-1 axis by CJC-1295, a long-acting GHRH analog, results in serum protein profile changes in normal adult subjects.

Authors:  Lucila Sackmann-Sala; Juan Ding; Lawrence A Frohman; John J Kopchick
Journal:  Growth Horm IGF Res       Date:  2009-04-21       Impact factor: 2.372

7.  O-Glycosylated 24 kDa human growth hormone has a mucin-like biantennary disialylated tetrasaccharide attached at Thr-60.

Authors:  Juan J Bustamante; Leticia Gonzalez; Christopher A Carroll; Susan T Weintraub; Roberto M Aguilar; Jesus Muñoz; Andrew O Martinez; Luis S Haro
Journal:  Proteomics       Date:  2009-07       Impact factor: 3.984

Review 8.  Perspective: proteomic approach to detect biomarkers of human growth hormone.

Authors:  Juan Ding; Edward O List; Shigeru Okada; John J Kopchick
Journal:  Growth Horm IGF Res       Date:  2009-06-04       Impact factor: 2.372

9.  Human growth hormone proteoform pattern changes in pituitary adenomas: Potential biomarkers for 3P medical approaches.

Authors:  Biao Li; Xiaowei Wang; Chenguang Yang; Siqi Wen; Jiajia Li; Na Li; Ying Long; Yun Mu; Jianping Liu; Qin Liu; Xuejun Li; Dominic M Desiderio; Xianquan Zhan
Journal:  EPMA J       Date:  2021-03-03       Impact factor: 6.543

10.  The use of variations in proteomes to predict, prevent, and personalize treatment for clinically nonfunctional pituitary adenomas.

Authors:  Xianquan Zhan; Dominic M Desiderio
Journal:  EPMA J       Date:  2010-06-29       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.